Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis.
Shin SH, Kim JH, Jeon YW, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ. Shin SH, et al. Among authors: jeon yw. Eur J Haematol. 2014 Jul;93(1):19-28. doi: 10.1111/ejh.12287. Epub 2014 Mar 7. Eur J Haematol. 2014. PMID: 24527665
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Yahng SA, Kim JH, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ. Yahng SA, et al. Among authors: jeon yw. Biol Blood Marrow Transplant. 2015 Jan;21(1):119-29. doi: 10.1016/j.bbmt.2014.09.029. Epub 2014 Oct 6. Biol Blood Marrow Transplant. 2015. PMID: 25300871 Free article.
Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21).
Eom KS, Kim HJ, Cho BS, Lee SE, Yahng SA, Yoon JH, Shin SH, Jeon YW, Kim JH, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. Eom KS, et al. Among authors: jeon yw. Acta Haematol. 2015;133(3):266-76. doi: 10.1159/000366261. Epub 2014 Nov 20. Acta Haematol. 2015. PMID: 25413265 Free article. Clinical Trial.
Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
Shin SH, Kim JH, Jeon YW, Yoon JH, Yahng SA, Lee SE, Choi YS, Kim DY, Lee JH, Lee S, Kim HJ, Min CK, Lee JW, Lee KH, Min WS, Kim YJ, Lee JH. Shin SH, et al. Among authors: jeon yw. Biol Blood Marrow Transplant. 2015 Feb;21(2):342-9. doi: 10.1016/j.bbmt.2014.10.031. Epub 2014 Nov 20. Biol Blood Marrow Transplant. 2015. PMID: 25459640 Free article.
Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.
Yoon JH, Jeon YW, Yahng SA, Shin SH, Lee SE, Cho BS, Lee DG, Eom KS, Kim HJ, Lee S, Min CK, Cho SG, Kim Y, Kim DW, Lee JW, Han K, Min WS, Park CW, Kim M, Kim YJ. Yoon JH, et al. Among authors: jeon yw. Biol Blood Marrow Transplant. 2015 Mar;21(3):460-7. doi: 10.1016/j.bbmt.2014.11.008. Epub 2014 Nov 20. Biol Blood Marrow Transplant. 2015. PMID: 25460359 Free article. Clinical Trial.
Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations.
Yoon JH, Kim HJ, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS. Yoon JH, et al. Among authors: jeon yw. Genes Chromosomes Cancer. 2015 Aug;54(8):489-499. doi: 10.1002/gcc.22260. Epub 2015 Jun 6. Genes Chromosomes Cancer. 2015. PMID: 26054017
209 results